0903 [Dow Jones] STOCK CALL: Credit Suisse raises ResMed (RMD.AU) target to A$5.30 from A$5.20 after RMD 4Q08 earnings were ahead of CS' estimates, reflecting a return to U.S. growth. "Top line revenue growth was the standout - American sales increased 14% versus a year earlier, underpinned by faster-than-expected traction of recent product releases," CS says in a client note. Keeps Neutral. "We believe that the early success of recent product launches and a pipeline of high margin releases scheduled for FY09 augurs well for continued top line revenue growth at least in line with industry average (15%)." Still, CS remains concerned about 300 basis-point margin decline in the past year due to currency, product mix and price discounting. Last trade A$4.60. (ABH)
credit suisse target..good news
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.66 |
Change
-0.940(2.50%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $36.32 | $36.69 | $36.13 | $46.16M | 1.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13944 | $36.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.71 | 12610 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
